Polyethylene Glycol Modification: Relevance of Improved Methodology to Tumour Targeting

References

• Abuchowski A., van Es T., Palczuk N. C., Davis F. F. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. (1977); 252: 3578–3581
   PubMed Web of Science ®Google Scholar
• Abuchowski A., Kazo G. M., Verhoest C. R., Jr, van Es X., Kafkewitz D., Nucci M. L., Viau A. T., Davis F. F. Cancer Therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem. Biophys. (1984); 7: 175–186
   PubMedGoogle Scholar
• Albertsson P. A. Partition of Cell Particles and Macromolecules. John Wiley and Sons, New York 1986
   Google Scholar
• Aldwin L., Nitecki D. E. A water-soluble, monitorable peptide and protein crosslinking agent. Anal. Biochem. (1987); 164: 494–501
   PubMed Web of Science ®Google Scholar
• Allen T. M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta (1991); 1066: 29–36
   PubMed Web of Science ®Google Scholar
• Allen T. M., Agrawal A. K., Ahmad I., Hansen C. B., Zalipsky S. Antibody-mediated targeting of long-circulating (Stealth) liposomes. J. Lipos. Res. (1994); 4: 1–25
   Google Scholar
• Allen T. M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. (1987); 223: 42–46
   PubMed Web of Science ®Google Scholar
• Ash R. C., Derrick D. A., Zanjani E. D. Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. Blood (1981); 58: 309–316
   PubMed Web of Science ®Google Scholar
• Beauchamp C. O., Gonias S. L., Menapace D. P., Pizzo S. V. A new procedure for the synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and alpha 2macroglobulin. Anal. Biochem. (1983); 131: 25–33
   PubMed Web of Science ®Google Scholar
• Beddu-Addo F. K., Klibanov A. L., Huang L. Effects of polyethyleneglycol-phospholipid conjugates on the phase transition of phosphatidylcholines and phosphatidyl-cholesterol mixtures. Liposome Research Days Conference Abstract. (1994), A-19. (Abstract)
   Google Scholar
• Blume G., Cevc G. Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta (1990); 1029: 91–97
   PubMed Web of Science ®Google Scholar
• Blume G., Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta (1993); 1146: 157–168
   PubMed Web of Science ®Google Scholar
• Carter M. C., Meyerhoff M. E. Instability of succinyl ester linkages in 02 monosuccinyl cyclic AMP-protein conjugates at neutral pH. J. Immunol. Methods (1985); 81: 245–257
   PubMed Web of Science ®Google Scholar
• Delgado C., Patel J. N., Francis G. E., Fisher D. Coupling of poly(ethylene glycol) to albumin under very mild conditions by activation with tresyl chloride: characterization of the conjugate by partitioning in aqueous two-phase systems. Biotechnol. Appl. Biochem. (1990); 12: 119–128
   PubMed Web of Science ®Google Scholar
• Delgado C., Francis G. E., Fisher D. Uses and properties of PEG-linked proteins. Crit. Rev. Ther. Drug Carrier Syst. (1992a); 9: 249–304
   PubMed Web of Science ®Google Scholar
• Delgado C., Sancho P., Mendieta J., Luque J. Ligand-receptor interactions in affinity cell partitioning. Studies with transferrin covalenly linked to monomethoxy(poly-ethylene glycol) and rat reticulocytes. J. Chromatogr. (1992b); 594: 97–103
   PubMed Web of Science ®Google Scholar
• Denekamp J. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol. (1993); 66: 181–196
   PubMed Web of Science ®Google Scholar
• Fisher D. Liposomes. European Patent EP 0 445 131 B1, 1989
   Google Scholar
• Forssen E. A., Coulter D. M., Proffitt R. T. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res. (1992); 52: 3255–3261
   PubMed Web of Science ®Google Scholar
• Forssen E. A., Ross M. E. Daunoxome treatment of solid tumours: preclinical and clinical investigations. J. Lipos. Res. (1994); 4: 481–512
   Google Scholar
• Francis G. E., Delgado C., Fisher D. PEG-modified proteins. Stability of Protein Pharmaceuticals: in vivo Pathways of Degradation and Strategies for Protein Stabilization (Pharmaceutical Biotechnology, T. J. Ahern, M. Manning. Plenum, New York 1991
   Google Scholar
• Gabizon A., Papahadjopoulos D. The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim. Biophys. Acta (1992); 1103: 94–100
   PubMed Web of Science ®Google Scholar
• Gabizon A. A. Selective tumor localisation and improved therapeutic index of anthracyclines encapsulated in long circulating liposomes. Cancer Res. (1992); 52: 891–896
   PubMed Web of Science ®Google Scholar
• Goodson R. J., Katre N. V. Site-directed pegylation of recombinant interleukin-2 at its glycosylation site. Biotechnology (1990); 8: 343–346
   PubMed Web of Science ®Google Scholar
• Harris J. M., Yoshinaga K., Paley M. S., Herati M. R. New activated PEG derivatives for affinity partitioning. Separations Using Aqueous Phase Systems. Applications in Cell Biology and Biotechnology, D. Fisher, LA. Sutherland. Plenum Press, London (1989); 203–210
   Google Scholar
• Harris J. M., Dust J. M., McGill R. A., Harris P. A., Edgell M. J., Sedaghat-Herati R. M., Karr L. J., Donnelly D. L. New polyethylene glycols for biomedical applications. Water-Soluble Polymers, S. W. Shalaby, C. L. McCormick, G. B. Butler. American Chemical Society, Washington, DC 1991
   Google Scholar
• Harris J. M. Poly (ethylene glycol) chemistry. Biotechnical and biomedical applications. Plenum Press, New York 1992
   Google Scholar
• Huang S. K., Mayhew E., Gilani S., Lasic D. D., Martin F. J., Papahadjopoulos D. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. (1992); 52: 6774–6781
   PubMed Web of Science ®Google Scholar
• Iwashita Y., Ajisaka K. Blood substitute containing modified hemoglobin. Ajinomoto Co. Incorp., Japan: United States Patent, 4,301,144., 1981
   Google Scholar
• Jain R. K., Baxter L. T. Extravasation and interstitial transport in tumours. Biological barriers to protein delivery, K. L. Aldus, T. J. Raub. Plenum Press, New York (1993); 441–465
   Google Scholar
• Katre N. V., Knauf M. J., Laird W. J. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc. Natl Acad. Sci. USA (1987); 84: 1487–1491
   PubMed Web of Science ®Google Scholar
• Kitamura K., Takahashi T., Takashina K., Yamaguchi T., Noguchi A., Tsurumi H., Toyokuni T., Hakomori S. Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localization. Biochem. Biophys. Res. Commun. (1990); 171: 1387–1394
   PubMed Web of Science ®Google Scholar
• Kitamura K., Takahashi T., Yamaguchi T., Noguchi A., Takashina K., Tsurumi H., Inagake M., Toyokuni T., Hakomori S. Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy. Cancer Res. (1991); 51: 4310–4315
   PubMedGoogle Scholar
• Kitamura T, Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Piao Y. F., Miyazono K., Urabe A., Takaku F. Establishment and characterization of a unique human cell line that proliferates dependency on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol- (1989); 140: 323–334
   PubMed Web of Science ®Google Scholar
• Knusli C., Delgado C., Malik F., Domine M., Tejedor M. C., Irvine A. E., Fisher D., Francis G. E. Polyethylene glycol (PEG) modification of granulocyte-macrophage colony stimulating factor (GM-CSF) enhances neutrophil priming activity but not colony stimulating activity. Br. J. Haematol. (1992); 82(4)654–663
   PubMed Web of Science ®Google Scholar
• Kuan C. T., Wang Q. C., Pastan I. Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner. J. Biol. Chem. (1994); 269: 7610–7616
   PubMed Web of Science ®Google Scholar
• Kuhl T. L., Leckband D. E., Lasic D. D., Israelachvili J. N. Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophys. J. (1994); 66: 1479–1488
   PubMed Web of Science ®Google Scholar
• Leaning M. S., Boroujerdi M. A. A system for compartmental modelling and simulation. Comput. Meth. Progr. Biomed. (1991); 35: 71–92
   PubMed Web of Science ®Google Scholar
• Ledermann J. A., Begent R. H., Massof C., Kelly A. M., Adam T., Bagshawe K. D. A phase-I study of repeated therapy with radiolabeled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response. Int. J. Cancer (1991); 47: 659–664
   PubMed Web of Science ®Google Scholar
• Lee I., Boucher Y., Jain R. K. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res. (1992); 52: 3237–3240
   PubMed Web of Science ®Google Scholar
• Lee I., Boucher Y., Demhartner T. J., Jain R. K. Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. Br. J. Cancer (1994); 69: 492–496
   PubMed Web of Science ®Google Scholar
• Lee R. J., Low P. S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. (1994); 269: 3198–3204
   Web of Science ®Google Scholar
• Leonard M., Neel J., Dellacherie E. Synthesis of monomethoxypolyoxyethylene-bound haemoglobins. Tetrahedron (1984); 40: 1585–1590
   Google Scholar
• Litzinger D. C., Buiting A. M., van Rooijen N., Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta (1994); 1190: 99–107
   PubMed Web of Science ®Google Scholar
• Litzinger D. C., Huang L. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen. Biochim. Biophys. Acta (1992); 1127: 249–254
   PubMed Web of Science ®Google Scholar
• Maeda H., Kai Y., Ono K. PEG derivatives, modified peptides and production thereof. EPA 0 340741., 1989
   Google Scholar
• Malik A. B., Siflinger-Birnboim A. Vascular endothelial barrier and its regulation. Biological barriers to protein delivery, K. L. Audus, T. J. Raub. Plenum, New York and London (1993); 231–260
   Google Scholar
• Malik F., Delgado C., Knusli C., Irvine A. E., Fisher D., Francis G. E. Polyethylene glycol (PEG) modified granulocyte-macrophage colony stimulating factor (GM-CSF) with conserved biological activity. Exp. Hematol. (1992); 20: 1028–1035
   PubMed Web of Science ®Google Scholar
• Martin F., Woodle M. C., Redemann C., Yau-Young A. Solid tumor treatment method and composition. Liposome Technology Inc.: World Patent Office WO91 05546, 1991
   Google Scholar
• Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation time in vivo of large unilamelar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly (ethylene glycol). Biochim. Biophys. Acta (1992); 1128: 44–49
   PubMed Web of Science ®Google Scholar
• Mayhew E. G., Lasic D., Babbar S., Martin F. J. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int. J. Cancer (1992); 51: 302–309
   PubMed Web of Science ®Google Scholar
• McGoff P., Baziotis A. C., Maskiewicz R. Analysis of polyethylene glycol modified superoxide dismutase by chromatographic, electrophoretic, light scattering, chemical and enzymatic methods. Chem. Pharm. Bull. Tokyo (1988); 36: 3079–3091
   PubMed Web of Science ®Google Scholar
• Naylor P. T., Larsen H. S., Huang L., Rouse B. T. In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes. Infect. Immun. (1982); 36: 1209–1216
   PubMed Web of Science ®Google Scholar
• Nilsson K., Mosbach K. Immobilization of enzymes and affinity ligands to various hydroxyl group carrying supports using highly reactive sulfonyl chlorides. Biochem. Biophys. Res. Commun. (1981); 102: 449–457
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D., Allen T. M., Gabizon A., Mayhew E., Matthay K., Huang S. K., Lee K. D., Woodle M. C., Lasic D. D., Redemann C. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA (1991); 88: 11460–11464
   PubMed Web of Science ®Google Scholar
• Parr M. J., Ansell S. M., Choi L. S., Cullis P. R. Factors influencing the retention and chemical stability of polyethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim. Biophys. Acta (1994); 1195: 21–30
   PubMed Web of Science ®Google Scholar
• Pizzo S. V. Preparation, in vivo properties and proposed clinical use of polyoxyethylene-modified tissue plasminogen activator and streptokinase. Advanced Drug Delivery Reviews (1991); 6: 153–166
   Web of Science ®Google Scholar
• Presant C. A., Blayney D., Proffitt R. T., Turner A. F., Williams L. E., Nadel H. I., Kennedy P., Wiseman C., Gala K., Crossley R. J. Preliminary report: imaging of Kaposi Sarcoma and Lymphoma in AIDS with Indium-111-labelled liposomes. Lancet (1990); 335: 1307–1309
   PubMed Web of Science ®Google Scholar
• Pyatak P. S., Abuchowski A., Davis F. F. Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity. Res. Commun. Chem. Pathol. Pharmacol (1980); 29: 113–127
   PubMedGoogle Scholar
• Richter A. W., Akerblom E. Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins. Int. Arch. Allergy Appl. Immunol (1983); 70: 124–131
   PubMedGoogle Scholar
• Rippe B., Haraldsson B. Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations. [Review]. Acta Physiol. Scand. (1987); 131: 411–428
   PubMedGoogle Scholar
• Sanchez Y., Ionescu-Matiu I., Dreesman G. R., Kramp W., Six H. R., Hollinger F. B., Melnick J. L. Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes. Infect. Immun. (1980); 30: 728–733
   PubMed Web of Science ®Google Scholar
• Sears B. D. Synthetic phospholipid compounds and their preparation. Lipid Specialities Inc.: European Patent Office, 0072 111, 1983
   Google Scholar
• Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta (1991); 1062: 77–82
   PubMed Web of Science ®Google Scholar
• Silvius J. R., Zuckermann M. J. Interbilayer transfer of phospholipid-anchored macromolecules via monomer diffusion. Biochemistry (1993); 32: 3153–3161
   PubMed Web of Science ®Google Scholar
• Snider J., Neville C., Yuan L. C., Bullock J. Characterization of the heterogeneity of polyethylene glycol-modified superoxide dismutase by chromatographic and electrophoretic techniques. J. Chromatogr. (1992); 599: 141–155
   PubMed Web of Science ®Google Scholar
• Teske E., Rutteman G. R., van Heerde P., Misdorp W. Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin's lymphoma. Eur. J. Cancer (1990); 26: 891–895
   PubMed Web of Science ®Google Scholar
• Tilcock C., Ahkong G. F., Koenig S. H., Brown R. D., III, Fisher D. Nuclear magnetic relaxation dispersion and 31p NMR studies of the effect of covlaent modifications of membrane surfaces with polyethylene glycol. Biochem. Biophys. Acta (1992); 1110: 193–198
   PubMed Web of Science ®Google Scholar
• Tilcock C., Ahkong Q. F., Fisher D. Polymer-derivatized technetium 99mTc-labeled liposomal blood pool agents for nuclear medicine applications. Biochim. Biophys. Acta (1993); 1148: 77–84
   PubMed Web of Science ®Google Scholar
• Tilcock C., Ahkong Q. F., Fisher D. 99mTc-Labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: Effect of Tin-to-chelate Ratio, chelate content and surface polymer on labeling efficiency and biodistribution behaviour. Nucl. Med. Biol. (1994); 21: 89–96
   PubMed Web of Science ®Google Scholar
• Tsuji J., Hirose K., Kasahara E., Naitoh M., Yamamoto I. Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase. Int. J. Immunopharmacol. (1985); 7: 725–730
   PubMed Web of Science ®Google Scholar
• Veronese F. M., Largajolli R., Boccu E., Benassi C. A., Schiavon O. Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase. Appl. Biochem. Biotechnol. (1985); 11: 141–152
   PubMed Web of Science ®Google Scholar
• Walter H., Brooks D. E., Fisher D. Partitioning in Aqueous Two-Phase Systems, Theory, Methods, Uses and Applications to Biotechnology. Academic Press, New York 1985
   Google Scholar
• Walter M. R., Cook W. J., Ealick S. E., Nagabhushan T. L., Trotta P. P., Bugg C. E. Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. J. Mol. Biol. (1992); 224: 1075–1085
   PubMed Web of Science ®Google Scholar
• Wie S. I., Wie C. W., Lee W. Y, Filion L. G., Sehon A. H., Akerblom E. Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method. Int. Arch. Allergy Appl Immunol. (1981); 64: 84–99
   PubMedGoogle Scholar
• Woodle M. C., Collins L. R., Sponsler E., Kossovsky N., Papahadjopoulos D. Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential. Biophys. J. (1992); 61: 902–910
   PubMed Web of Science ®Google Scholar
• Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., Inoue S. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. (1990); 50: 1693–1700
   PubMed Web of Science ®Google Scholar
• Yoshimoto T., Nishimura H., Saito Y., Sakurai K., Kamisaki Y., Wada H., Sako M., Tsujino G., Inada Y. Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn. J. Cancer Res. (1986); 77: 1264–1270
   PubMedGoogle Scholar
• Yoshimoto T., Ritani A., Ohwada K., Takahashi K., Kodera Y., Matsushima A., Saito Y., Inada Y. Polyethylene glycol derivative-modified cholesterol oxidase soluble and active in benzene. Biochem. Biophys. Res. Commun. (1987); 148: 876–582
   PubMed Web of Science ®Google Scholar
• Yoshinga K., Harris J. M. Effects of coupling chemistry on the activity of poly(ethylene glycol)-modified alkaline phosphatase. J. Bioactiv. Compatible Polym. (1989); 4: 17–24
   Google Scholar
• Yuan J. Estimation of variance for AUC in animal studies [letter]. J. Pharm. Sci. (1993); 82: 761–763
   PubMed Web of Science ®Google Scholar
• Zalipsky S. Active carbonates of polyethylene oxides for modification of polypeptides. WO, 90/13540., 1990
   Google Scholar
• Zalipsky S. Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. Bioconjug. Chem. (1993); 4: 296–299
   PubMed Web of Science ®Google Scholar
• Zalipsky S., Lee C. Use of functionalized polyethylene glycols for modification of polypeptides. Biomedical Applications of Polyethylene Glycol Chemistry, J. M. Harris. Plenum, New York 1992
   Google Scholar